Qiagen NV | QIA - Ebitda

Stock Price
41.18
Daily Change
0.06 0.15%
Monthly
-11.31%
Yearly
8.84%
Q1 Forecast
40.37

Qiagen NV reported $249.69M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
argenx SE USD 288.02M 84.53M Jun/2025
Avita Medical AUD -21.9M 12.04M Jun/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Moderna USD -790M 582M Dec/2025
Organon & Co USD 383M 135M Dec/2025
Qiagen NV USD 249.69M 56.53M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Tectonic Therapeutic USD -13.48M 5.73M Dec/2024
Viatris USD 1.15B 75.8M Sep/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025